- Recent Funding
- Investors
- Eventide Asset Management
E
Eventide Asset Management
Eventide Asset Management has backed 1 company on Recent Funding, 1 in the last 12 months; its most recent deal is AdvanCell (2026-07-15).
What Eventide Asset Management invests in
- Health and bio · 1 · 100%
How Eventide Asset Management invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series b+ | 1 100% | $315M |
Share is of the 1 round on Recent Funding that name Eventide Asset Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio
| Company | Round with Eventide Asset Management | Total raised | Latest raise |
|---|---|---|---|
 AAdvanCellHealth and bio |
Series b+ · $315M | $439.5M | Jul 15, 2026 Series b+ |
Most frequent co-investors
CCatalio1 shared round · last Jul 15, 2026
- FFidelity Management & Research Company1 shared round · last Jul 15, 2026
- TT. Rowe Price1 shared round · last Jul 15, 2026
- EEli Lilly and Company1 shared round · last Jul 15, 2026
- MMorningside1 shared round · last Jul 15, 2026
- SSV Health Investors1 shared round · last Jul 15, 2026
- SSanofi Ventures1 shared round · last Jul 15, 2026
- AAbingworth1 shared round · last Jul 15, 2026
- SSymBiosis1 shared round · last Jul 15, 2026
- TTenmile1 shared round · last Jul 15, 2026
- BBrandon Capital1 shared round · last Jul 15, 2026
- AAlly Bridge Group1 shared round · last Jul 15, 2026
Portfolio companies are the companies on Recent Funding with a round that lists Eventide Asset Management, which is a subset of its real portfolio. API: /api/v1/investors/eventide-asset-management. All investors.
Catch them early
Stealth builders and new accelerator batches, weekly.
Unsubscribe anytime · privacy